Cargando…

Metabolomics Identifies Biomarker Signatures to Differentiate Pancreatic Cancer from Type 2 Diabetes Mellitus in Early Diagnosis

METHODS: Plasma metabolic profiles in 26 PC patients, 27 DM patients, and 23 healthy volunteers were examined using an ultraperformance liquid chromatography coupled with tandem mass spectrometry platform. Differential metabolite ions were then identified using the principal component analysis (PCA)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Hongmin, Zhang, Lei, Kang, Hua, Liu, Jie, Zhang, Jiandong, Zhao, Jie, Liu, Shuye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639267/ https://www.ncbi.nlm.nih.gov/pubmed/34868309 http://dx.doi.org/10.1155/2021/9990768

Ejemplares similares

Clinical Parameters and Metabolomic Biomarkers That Predict Inhospital Outcomes in Patients With ST-Segment Elevated Myocardial Infarctions
por: Liu, Jie, et al.
Publicado: (2022)

Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer
por: Liu, Chang, et al.
Publicado: (2022)

The prognostic analysis of different metastatic patterns in pancreatic neuroendocrine tumors patients: A population based analysis
por: Wang, Sumei, et al.
Publicado: (2019)

Serum metabolomics differentiating pancreatic cancer from new-onset diabetes
por: He, Xiangyi, et al.
Publicado: (2017)

Metabolomics Reveals Molecular Signatures for Psoriasis Biomarkers and Drug Targets Discovery
por: Song, Qian, et al.
Publicado: (2023)

Identifying therapeutic biomarkers of zoledronic acid by metabolomics
por: Li, Xiang, et al.
Publicado: (2023)

A clinical metabolomics-based biomarker signature as an approach for early diagnosis of gastric cardia adenocarcinoma
por: Sun, Yuanfang, et al.
Publicado: (2020)

A multi-subgroup predictive model based on clinical parameters and laboratory biomarkers to predict in-hospital outcomes of plasma exchange-centered artificial liver treatment in patients with hepatitis B virus-related acute-on-chronic liver failure
por: Liu, Jie, et al.
Publicado: (2023)

Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
por: Mayerle, Julia, et al.
Publicado: (2018)

Qualitative Transcriptional Signature for the Pathological Diagnosis of Pancreatic Cancer
por: Zhou, Yu-Jie, et al.
Publicado: (2020)

Serum and Soleus Metabolomics Signature of Klf10 Knockout Mice to Identify Potential Biomarkers
por: Baroukh, Nadine, et al.
Publicado: (2022)

Correction: Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
Publicado: (2018)

Integrated Analysis Identifies a Nine-microRNA Signature Biomarker for Diagnosis and Prognosis in Colorectal Cancer
por: Di, Ziyang, et al.
Publicado: (2020)

High-resolution metabolomic biomarkers for lung cancer diagnosis and prognosis
por: Qi, Shi-ang, et al.
Publicado: (2021)

Metabolomic Biomarker Signatures for Bipolar and Unipolar Depression
por: Tomasik, Jakub, et al.
Publicado: (2023)

Serum metabolic signatures for acute pulmonary embolism identified by untargeted metabolomics
por: Xie, Ming, et al.
Publicado: (2023)

Identifying network biomarkers of cancer by sample-specific differential network
por: Zhang, Yu, et al.
Publicado: (2022)

Metabolomics research on potential role for 9‐cis‐retinoic acid in breast cancer progression
por: Wu, Jing, et al.
Publicado: (2018)

Application of Metabolomics to Identify Potential Biomarkers for the Early Diagnosis of Coronary Heart Disease
por: Jiang, Huali, et al.
Publicado: (2021)

The amino acid metabolomics signature of differentiating myocardial infarction from strangulation death in mice models
por: Wang, Song-Jun, et al.
Publicado: (2023)

Differential correlation network analysis identified novel metabolomics signatures for non-responders to total joint replacement in primary osteoarthritis patients
por: Costello, Christie A., et al.
Publicado: (2020)

Untargeted plasma metabolome identifies biomarkers in patients with extracranial arteriovenous malformations
por: Fan, Xueqiang, et al.
Publicado: (2023)

A novel messenger RNA signature as a prognostic biomarker for predicting relapse in pancreatic ductal adenocarcinoma
por: Shi, Guodong, et al.
Publicado: (2017)

Metabolic biomarkers for the differential diagnosis of pancreatic ductal adenocarcinoma vs. chronic pancreatitis
por: Mayerle, Julia, et al.
Publicado: (2014)

Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study
por: Zhao, Rui, et al.
Publicado: (2022)

Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics
por: Martín-Blázquez, Ariadna, et al.
Publicado: (2020)

A Multi-Platform Metabolomics Approach Identifies Urinary Metabolite Signatures That Differentiate Ketotic From Healthy Dairy Cows
por: Zhang, Guanshi, et al.
Publicado: (2021)

Metabolomic Signature of Coronary Artery Disease in Type 2 Diabetes Mellitus
por: Stratmann, Bernd, et al.
Publicado: (2017)

Integration of metabolomics and transcriptomics reveals major metabolic pathways and potential biomarkers involved in aging mice with type 2 diabetes mellitus
por: Meng, Jie, et al.
Publicado: (2022)

Perspectives from metabolomics in the early diagnosis and prognosis of gestational diabetes mellitus
por: Zhang, Muqiu, et al.
Publicado: (2022)

Untargeted Metabolomics for the Diagnosis of Exocrine Pancreatic Insufficiency in Chronic Pancreatitis
por: Díaz, Caridad, et al.
Publicado: (2021)

(1)H-NMR spectroscopy identifies potential biomarkers in serum metabolomic signatures for early stage esophageal squamous cell carcinoma
por: Liu, Yan-Yan, et al.
Publicado: (2019)

An eight cytokine signature identified from peripheral blood serves as a fingerprint for hepatocellular cancer diagnosis
por: Shen, Jing, et al.
Publicado: (2018)

Differential Diagnosis of Cystic Pancreatic Lesions Including the Usefulness of Biomarkers
por: Lévy, Philippe, et al.
Publicado: (2015)

Biochemical Intracystic Biomarkers in the Differential Diagnosis of Pancreatic Cystic Lesions
por: Wietrzykowska-Grishanovich, Dominika, et al.
Publicado: (2022)

Airway Microbiome and Serum Metabolomics Analysis Identify Differential Candidate Biomarkers in Allergic Rhinitis
por: Yuan, Yuze, et al.
Publicado: (2022)

Identification of Metabolomic Biomarkers of Seed Vigor and Aging in Hybrid Rice
por: Chen, Bing-Xian, et al.
Publicado: (2022)

A novel class of tsRNA signatures as biomarkers for diagnosis and prognosis of pancreatic cancer
por: Jin, Fangfang, et al.
Publicado: (2021)

Assessment of ferroptosis-associated gene signatures as potential biomarkers for differentiating latent from active tuberculosis in children
por: Chen, Liang, et al.
Publicado: (2023)

The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis prediction
por: Tan, Zhen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j2dd0ig768ovljquk70537kdot